Declaration of candidacy definition

Declaration of candidacy means the document filed by a candidate for an office that requires
Sample 1Sample 2Sample 3
Declaration of candidacy means, for the purpose of this Chapter, announcing candidacy through a publication of general circulation, by news media announcement, or upon commencement of fundraising activities, whichever occurs first. (PR16-020, 5/26/99)
Sample 1
Declaration of candidacy means, for the purpose of this Chapter, filing for elective office, announcing candidacy through a publication or webpage of general circulation, by news media announcement, or upon commencement of fundraising activities, whichever occurs first.
Sample 1

Examples of Declaration of candidacy in a sentence

  • Declaration of candidacy for election to City office shall be made by declaration of candidacy filed with the City Clerk.

  • Declaration of candidacy for election to city office shall be made by declaration of candidacy filed with the City Clerk.

  • Declaration of candidacy forms shall be readily available to members.

  • Jack Bell was provided the appropriate materials and instructions for Petition and Declaration of candidacy.

  • Declaration of candidacy for any one office shall be deemed as notification the candidate will not accept the candidacy, write-in or otherwise, for any other office in the election.

  • Provided the Parties have met their obligations under Section 8.A, the Parties shall be entitled to pursue such remedies as may be available in law and equity.

  • Declaration of candidacy forms may be obtained from the Clerk at the municipal offices from 9:00 a.m. to 4:00 p.m. Monday through Thursday, and 9:00 a.m. to 12:00 p.m. every Friday.DECLARATIONS WILL NOT BE ACCEPTED ON WEEKENDS OR STATE OBSERVED HOLIDAYS.The last day to file declaration of candidacy is FRIDAY, SEPTEMBER 4, 2020.The last day to withdrawal declarations of candidacy is also FRIDAY, SEPTEMBER 4, 2020.QUALIFICATIONS:A person filing for election to a seat on the governing body must be:1.

  • Declaration of candidacy for elected City offices shall be made with the City Clerk at City Hall in the form and manner prescribed by ordinance.

  • Declaration of candidacy forms and petition of qualified voter forms are published on the RCDC website or available by request from the RCDC Chair.

  • Becoming a member of a local board of education -- Declaration of candidacy -- Election.


More Definitions of Declaration of candidacy

Declaration of candidacy means the point in a person's
Sample 1

Related to Declaration of candidacy

  • IND means an investigational new drug application filed with the FDA with respect to a Product, or an equivalent application filed with a Regulatory Authority in a country other than the United States to commence a clinical trial of pharmaceutical product.

  • MAA means a Marketing Authorization Application, in relation to any Product, filed or to be filed with the EMA (or equivalent national agency), for authorization to place a medicinal product on the market in the European Union (or any other territory).

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Clinical Trial means any human clinical trial of a Product.

  • Regulatory Filing means any filing with any Governmental Authority with respect to the research, development, manufacture, distribution, pricing, reimbursement, marketing or sale of a Product.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Pivotal Clinical Trial means a human clinical trial in any country that is prospectively designed to generate data intended to satisfy the requirements of 21 C.F.R. § 312.21(c) (as amended) in the U.S. or a similar clinical study prescribed by a Regulatory Authority from another country, from time to time, pursuant to Applicable Law.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Board of Studies means the Board of Studies of the University;

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Joint Proxy Statement has the meaning set forth in Section 6.03(a).

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Regulatory Filings means all applications, filings, dossiers and the like submitted to a Regulatory Authority in a particular jurisdiction for the purpose of obtaining Regulatory Approval of a Licensed Product from that regulatory authority with respect to such jurisdiction. Regulatory Filings shall include, but not be limited to, all INDs and Drug Approval Applications for Licensed Product.

  • Joint Patent Committee or “JPC” has the meaning set forth in Section 7.1.3(a).

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Exempt compound means the same as defined in Rule 2.